Business · 09/01/2006
FDA Requests Comments on Guidance for Using Leftover Human Specimens in IVD Device Studies
The FDA is seeking public input on a proposed guidance document that outlines the possibility of conducting In Vitro Diagnostic device studies using leftover human specimens without individual informed consent, while protecting the human subjects.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →